Genome-Wide Association Study of Accessory Atrioventricular Pathways
Authors: Hildur M. Aegisdottir, Laura Andreasen, Rosa B. Thorolfsdottir, Gardar Sveinbjornsson, Andrea B. Jonsdottir, Lilja Stefansdottir, Gudmar Thorleifsson, Asgeir Sigurdsson, Gisli H. Halldorsson, Julien Barc, Floriane Simonet, Vinicius Tragante, Asmundur Oddsson, Egil Ferkingstad, Jesper Hastrup Svendsen, Jonas Ghouse, Gustav Ahlberg, Christian Paludan-Müller, Katra Hadji-Turdeghal, Mariana Bustamante, Magnus O. Ulfarsson, Anna Helgadottir, Solveig Gretarsdottir, Saedis Saevarsdottir, Ingileif Jonsdottir, Christian Erikstrup, Henrik Ullum, Erik Sørensen, Søren Brunak, Christian Jøns, Chaoqun Zheng, Connie R. Bezzina, Kirk U. Knowlton, Lincoln D. Nadauld, Patrick Sulem, Sisse R. Ostrowski, Ole B. Pedersen, David O. Arnar, Daniel F. Gudbjartsson, Morten S. Olesen, Henning Bundgaard, Hilma Holm, Kari Stefansson, Karina Banasik, Jakob Bay, Jens K. Boldsen, Thorsten Brodersen, Søren Brunak, Alfonso Buil Demur, Lea A. N. Christoffersen, Maria Didriksen, Khoa M. Dinh, Joseph Dowsett, Christian Erikstrup, Bjarke Feenstra, Frank Geller, Daniel Gudbjartsson, Thomas F. Hansen, Dorte Helenius Mikkelsen, Lotte Hindhede, Henrik Hjalgrim, Jakob H. V. Stemann, Bitten A. Jensen, Andrew Joseph Schork, Katrine Kaspersen, Bertram D. Kjerulff, Mette Kongstad, Susan Mikkelsen, Christina Mikkelsen, Ioanna Nissen, Mette Nyegaard, Sisse R. Ostrowski, Ole B. Pedersen, Liam J. E. Quinn, Þórunn Rafnar, Palle D. Rohde, Klaus Rostgaard, Michael Schwinn, Kari Stefansson, Hreinn Stefánsson, Erik Sørensen, Unnur Thorsteinsdóttir, Lise W. Thørner, Mie Topholm Bruun, Henrik Ullum, Thomas Werge, David Westergaard
Journal: JAMA Cardiology (2024)

Importance Understanding of the genetics of accessory atrioventricular pathways (APs) and affiliated arrhythmias is limited. Objective To investigate the genetics of APs and affiliated arrhythmias. Design, Setting, and Participants This was a genome-wide association study (GWAS) of APs, defined by International Classification of Diseases ( ICD ) codes and/or confirmed by electrophysiology (EP) study. Genome-wide significant AP variants were tested for association with AP-affiliated arrhythmias: paroxysmal supraventricular tachycardia (PSVT), atrial fibrillation (AF), ventricular tachycardia, and cardiac arrest. AP variants were also tested in data on other heart diseases and measures of cardiac physiology. Individuals with APs and control individuals from Iceland (deCODE Genetics), Denmark (Copenhagen Hospital Biobank, Danish Blood Donor Study, and SupraGen/the Danish General Suburban Population Study [GESUS]), the US (Intermountain Healthcare), and the United Kingdom (UK Biobank) were included. Time of phenotype data collection ranged from January 1983 to December 2022. Data were analyzed from August 2022 to January 2024. Exposures Sequence variants. Main Outcomes and Measures Genome-wide significant association of sequence variants with APs. Results The GWAS included 2310 individuals with APs (median [IQR] age, 43 [28-57] years; 1252 [54.2%] male and 1058 [45.8%] female) and 1 206 977 control individuals (median [IQR] year of birth, 1955 [1945-1970]; 632 888 [52.4%] female and 574 089 [47.6%] male). Of the individuals with APs, 909 had been confirmed in EP study. Three common missense variants were associated with APs, in the genes CCDC141 (p.Arg935Trp: adjusted odds ratio [aOR], 1.37; 95% CI, 1.24-1.52, and p.Ala141Val: aOR, 1.55; 95% CI 1.34-1.80) and SCN10A (p.Ala1073Val: OR, 1.22; 95% CI, 1.15-1.30). The 3 variants associated with PSVT and the SCN10A variant associated with AF, supporting an effect on AP-affiliated arrhythmias. All 3 AP risk alleles were associated with higher heart rate and shorter PR interval, and have reported associations with chronotropic response. Conclusions and Relevance Associations were found between sequence variants and APs that were also associated with risk of PSVT, and thus likely atrioventricular reentrant tachycardia, but had allele-specific associations with AF and conduction disorders. Genetic variation in the modulation of heart rate, chronotropic response, and atrial or atrioventricular node conduction velocity may play a role in the risk of AP-affiliated arrhythmias. Further research into CCDC141 could provide insights for antiarrhythmic therapeutic targeting in the presence of an AP.